DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Park SH, Ryu MH, Ryoo BY et al.
Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group.
Invest New Drugs 2012;
30: 2377-2383
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.